Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
24
Películas cinematográficas
16
Música popular
13
Novela estadounidense
12
Jazz
10
Música para órgano
7
Crítica e interpretación
6
Música rock
6
Correspondencia
5
Comedy films
4
Condiciones sociales
4
Diarios íntimos
4
Estados Unidos
4
Música
4
Música vocal (Jazz)
4
Novelistas ingleses
4
Arte
3
Aspectos sociales
3
Bailarines
3
Blues (Música)
3
Christmas music
3
Foreign films
3
Historia y crítica
3
Libros falsos
3
Literatura estadounidense
3
Motetes
3
Música de jazz
3
Operas
3
Songs (High voice) with piano
3
Songs (Medium voice) with piano
3
-
6141por Wang, Yan, Jing, Ming-Xi, Jiang, Lei, Jia, Yu-Feng, Ying, E., Cao, Hui, Guo, Xiang-Yu, Sun, Tao“…Therefore, this trial was designed to observe whether irinotecan with a ketogenic diet can promote sensitivity to chemotherapy and remit target lesions in locally recurrent or metastatic Her-2-negative breast cancer patients. METHODS/DESIGN: This trial aims to recruit 518 women with locally recurrent or metastatic breast cancer admitted to the Liaoning Cancer Hospital and Institute (Shenyang, China) in northeast China. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6142por De Angelis, C., Bruzzese, D., Bernardo, A., Baldini, E., Leo, L., Fabi, A., Gamucci, T., De Placido, P., Poggio, F., Russo, S., Forestieri, V., Lauria, R., De Santo, I., Michelotti, A., Del Mastro, L., De Laurentiis, M., Giuliano, M., De Placido, S., Arpino, G.“…BACKGROUND: We evaluated the efficacy and safety of the nontaxane microtubule dynamics inhibitor eribulin plus the humanized anti-VEGF monoclonal antibody bevacizumab in a novel second-line chemotherapy scheme in HER2-negative metastatic breast cancer (MBC) patients progressing after first-line paclitaxel and bevacizumab. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6143por Buehler, Anna Maria, Castilho, Gabriela, Dionne, Pierre-Alexandre, Stefani, Stephen“…CDK 4/6 inhibitors represent a paradigm shift in the treatment of advanced BC HR+/HER2−, given the clinically and statistically significant gain in overall survival associated with this new class of medications. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6144“…Approximately 70% of breast cancer (BC) cases are hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) BC. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have acted as star drugs for reversing endocrine therapy (ET) resistance and improving the prognosis of patients with HR+ advanced breast cancer (ABC) since they were initially approved. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6145por Gwark, Sungchan, Ahn, Sei Hyun, Noh, Woo Chul, Lee, Eun Sook, Jung, Yongsik, Kim, Lee Su, Han, Wonshik, Nam, Seok Jin, Gong, Gyungyub, Kim, Seon-Ok, Kim, Hee JeongEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6146“…Protein levels of c-Met, Her-3 and IGF-1R were assessed by western blotting. miRNA-mRNA interaction was investigated by luciferase reporter assay and AGO2-RIP. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6147por Giannitti, Federico, Aráoz, Virginia, da Silva Silveira, Caroline, Francia, María E., Robello, Carlos, Cabrera, Andrés“…This is the first description of one same dam transmitting two N. caninum genotypes to her offspring in subsequent gestations.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6148por Staropoli, Nicoletta, Geuna, Elena, Rinaldi, Gaetana, Bisagni, Giancarlo, Scotti, Vieri, Faggioni, Giovanni, Vannini, Laura, Arcara, Carlo, Moretti, Gabriella, Gunnellini, Marco, Coltelli, Luigi, Verderame, Francesco, Livi, Lorenzo, Sanna, Giuseppina, Grasso, Donatella, Abbinante, Giulia, Ragni, Francesca“…Our work confirms that ribociclib in combination with endocrine therapy is highly effective in the treatment of premenopausal HR+/HER2− advanced breast cancer patients with an expected safety profile.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6149“…BACKGROUND: (111)In[In]-BnDTPA-trastuzumab-NLS is a radiopharmaceutical with theranostic applications for imaging and Meitner-Auger electron (MAE) radioimmunotherapy (RIT) of HER2-positive breast cancer (BC). Nuclear localization sequence (NLS) peptides route the radiopharmaceutical to the nucleus of HER2-positive BC cells following receptor-mediated internalization for RIT with subcellular range MAEs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
6150
-
6151
-
6152
-
6153
-
6154
-
6155
-
6156
-
6157
-
6158
-
6159
-
6160